Search

Search Constraints

You searched for: Author/Creator Scribano, Maria Lia

Search Results

3. Cancer Risk in Inflammatory Bowel Disease: A 6-Year Prospective Multicenter Nested Case–Control IG-IBD Study. Issue 3 (11th February 2020)

4. Corrigendum to "Expert consensus paper on the use of Vedolizumab for the management of patients with moderate-to-severe Inflammatory Bowel Disease" [Dig. Liver Dis. 48 (2016) 360–370]. Issue 9 (September 2016)

6. Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG‐IBD LIVE study. Issue 1 (12th May 2022)

7. Effectiveness of adalimumab for ulcerative colitis: A multicentre, retrospective study of clinical practice in Italy. Issue 3 (March 2022)

8. Effectiveness of ustekinumab in patients with refractory Crohn's disease: a multicentre real-life study in Italy. (February 2022)

9. Efficacy and safety of biosimilar CT-P13 compared with originator infliximab in patients with active Crohn's disease: an international, randomised, double-blind, phase 3 non-inferiority study. Issue 10182 (27th April 2019)

10. Female reproductive health and inflammatory bowel disease: A practice-based review. Issue 1 (January 2022)